Literature DB >> 30104853

Anesthetic management of a patient with MELAS.

Suma Mary Thampi1, Chitra Srinivasan1, Gladdy George1, Kirubakaran Davis1.   

Abstract

Entities:  

Year:  2018        PMID: 30104853      PMCID: PMC6066873          DOI: 10.4103/0970-9185.173379

Source DB:  PubMed          Journal:  J Anaesthesiol Clin Pharmacol        ISSN: 0970-9185


× No keyword cloud information.
Madam, Mitochondrial diseases (MDs) have an incidence of 1:4000 live births.[1] With advancing diagnostic and treatment facilities, increasing number of patients present for anesthesia for diagnostic procedures or palliative surgeries. MELAS is a subgroup of MDs characterized by mitochondrial encephalomyopathy, lactic acidosis, and stroke. These diseases have variable clinical presentation with multisystem involvement [Table 1]. Although clues to the disease may manifest in early years, most cases become clinically symptomatic after late childhood. Pediatric onset disease is more progressive with neurological, cardiac and liver dysfunction. These patients have increased sensitivity to most drugs used in anesthesia [Table 2]. However, to the best of our knowledge, there are no reports of any adverse events with ketamine and fentanyl in MD patients.
Table 1

Typical features of MELAS

Table 2

Effects of anesthetics in MD

Typical features of MELAS Effects of anesthetics in MD We report a 9-year-old girl, weighing 19 kg, with MELAS, and recurrent aspiration pneumonia due to bulbar involvement. She was on nasogastric tube (NGT) feeds and was planned for laparoscopic gastrostomy under general anesthesia. On examination, she was alert, conscious and dysarthric. Her respiratory rate was 30/min, oxygen saturation 93% on room air and 96% with oxygen supplementation. Bilateral coarse crepitations were present. Chest X-ray showed features suggestive of aspiration pneumonia. In view of her pulmonary condition and increased vulnerability to anesthetic agents, an open procedure was settled on, after discussion with the surgeons, under a combination of sedation with fentanyl-ketamine and local field block. She was adequately fasted, while maintained on dextrose containing intravenous fluid to avoid increasing metabolic burden. The risk of potential aspiration was considered minimal as she was kept NPO adequately, in addition to the presence of NGT allowing for suctioning of gastric contents (if any). After establishing intravenous access and routine monitoring, ketamine 10 mg bolus (0.5 mg/kg) was given with which the child fell asleep. Subsequently, a field block was given with a mixture of 0.2% ropivacaine and 1% lignocaine. Fentanyl 5 mcg (0.25 mcg/kg) was given just before skin incision. With these minimal doses, the respiratory rate fell to 3/min. A pediatric open circuit was used to assess respiration and assist if necessary. The child did not have any response to surgical incision, neither did she require any further doses. The procedure was completed successfully at the end of which she was shifted to a high dependency unit for monitoring. Though Markham et al. state that ketamine has been shown to inhibit oxidation in mitochondria in animal models,[2] there is paucity in literature on its untoward effects in patients with MD. In our patient, we chose ketamine for its analgesic effects, bronchodilatory properties and ability to maintain airway reflexes as well as spontaneous respiration. There are no adverse reports with the use of fentanyl either, except at higher doses.[3] However, we found an increased sensitivity to even a very minimal dose of both drugs, as manifested by a significant drop in respiratory rate. Close monitoring of the patient helped avert an untoward event. However, we wish to highlight that even these seemingly safe agents should be titrated to patient needs very cautiously, rather than a standard weight-based dosing. Two large cases series reported suggest the possibility of safe anesthesia with appropriate preoperative assessment and monitoring.[45] Nonetheless, it is also important to be aware of reports of delayed worsening of respiratory function with or without neurologic degeneration in mildly affected patients whose anesthetic course had been notably uneventful.[678] Choosing between local, regional, or general anesthesia, depends on the patient (tolerability of an awake procedure, degree of neuropathy/myopathy, spinal cord involvement) as well as nature of surgery (degree of muscle relaxation required, postoperative analgesia). Even in the absence of negative literature, it should be considered that the requirement of any agent may be lower than in normal individuals, and titration of drugs to effect is more appropriate than a weight-based nomogram. It will be prudent to remember that a successful use of one agent in a patient does not mean that the agent is safe to use in all, but may simply be due to a biased reporting.
  8 in total

1.  Perioperative white matter degeneration and death in a patient with a defect in mitochondrial oxidative phosphorylation.

Authors:  A Casta; E J Quackenbush; C S Houck; M S Korson
Journal:  Anesthesiology       Date:  1997-08       Impact factor: 7.892

2.  The effect of ketamine hydrochloride, a non-barbiturate parenteral anaesthetic on oxidative phosphorylation in rat liver mitochondria.

Authors:  A Markham; I Cameron; S J White
Journal:  Biochem Pharmacol       Date:  1981-08-01       Impact factor: 5.858

3.  Anesthesia-related morbidity and mortality after surgery for muscle biopsy in children with mitochondrial defects.

Authors:  Jacques Driessen; Simone Willems; Sander Dercksen; Janneke Giele; Frans van der Staak; Jan Smeitink
Journal:  Paediatr Anaesth       Date:  2007-01       Impact factor: 2.556

Review 4.  Neuromuscular and mitochondrial disorders: what is relevant to the anaesthesiologist?

Authors:  Jacques J Driessen
Journal:  Curr Opin Anaesthesiol       Date:  2008-06       Impact factor: 2.706

Review 5.  Mitochondrial disorders and general anaesthesia: a case series and review.

Authors:  E J Footitt; M D Sinha; J A J Raiman; A Dhawan; S Moganasundram; M P Champion
Journal:  Br J Anaesth       Date:  2008-02-19       Impact factor: 9.166

6.  Acute respiratory failure precipitated by general anesthesia in Leigh's syndrome.

Authors:  P J Grattan-Smith; L K Shield; I J Hopkins; K J Collins
Journal:  J Child Neurol       Date:  1990-04       Impact factor: 1.987

Review 7.  Mitochondrial myopathies and anaesthesia.

Authors:  E A Shipton; D O Prosser
Journal:  Eur J Anaesthesiol       Date:  2004-03       Impact factor: 4.330

8.  Anesthesia for corrective spinal surgery in a patient with Leigh's disease.

Authors:  Michael A Cooper; Richard Fox
Journal:  Anesth Analg       Date:  2003-11       Impact factor: 5.108

  8 in total
  1 in total

1.  Fentanyl can be mitochondrion -toxic depending on dosage and cell type.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2019 Oct-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.